Insider Purchase by Foresite Capital Management V, LLC (10% Owner)
Trade Summary
1 month ago, Foresite Capital Management V, LLC, serving as 10% owner Owner at Latigo Biotherapeutics, Inc. (LTGO), purchased 140,000 shares at $18.00 per share, for a total transaction value of $2,520,000.00. Following this transaction, Foresite Capital Management V, LLC now holds 2,008,024 shares of LTGO.
This purchase represents a 7.49% increase in Foresite Capital Management V, LLC's stake in the company. This is considered a high-conviction trade given the significant change in ownership.
The trade was executed on Monday, August 10, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, August 11, 2026 (accepted Aug 10, 8:21 PM ET), 1 day after the trade was made.
Latigo Biotherapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.
Trade Price
$18.00
Quantity
140,000
Total Value
$2,520,000.00
Shares Owned
2,008,024
Trade Date
47 days ago
SEC Filing Date
(accepted Aug 10, 8:21 PM ET)
Filed 1 day after trade
Discussion